Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by WORKINMONTANA


V.CLAS.H

RE:Sedar Filings

KALYTERA THERAPEUTICS, INC. MANAGEMENT’S DISCUSSION AND ANALYSIS OF...

November 29, 2018

V.CLAS.H

RE:do you guys see it going further down?

How long does the filing process of a patent take?  That is your answer....

November 29, 2018

V.CLAS.H

RE:RE:RE:RE:RE:S6V4.F - KALY on Frankfurt

https://twitter.com/fcharron514/status/1048294815870459904?s=21 follow this...

October 5, 2018

V.CLAS.H

RE:RE:RE:S6V4.F - KALY on Frankfurt

Up up up 52.78% today snooze you loose 

October 5, 2018

V.CLAS.H

We Expect Our Phase 3 Study to Start Later this Year

KALYTERA THERAPEUITCS Letter to Shareholders Why is the market sleeping on...

May 1, 2018

V.CLAS.H

RE:Company to Focus Resources on GVHD and Pain Programs

“The decision to terminate these programs is part of our overall strategy to...

April 14, 2018

V.CLAS.H

Company to Focus Resources on GVHD and Pain Programs

Click on the link below. Good Read from BIO Portfolio.com posted in the last...

April 14, 2018

V.CLAS.H

More From Kalytera's Twitter Feed

@KALYTERACO (Click Link) Following two #StemCell transplants, Jonathan Pitre...

March 21, 2018

V.CLAS.H

KALYTERA'S Twitter Feed 3:01PM ET Something Big Is Brewing

@kalyterco Kalytera's program for the treatment of pain is a first step...

March 20, 2018

V.CLAS.H

RE:RE:RE:Not sure if the coming news will be related but:

Puns of "Branching Out" while in the business world. 1. Dont Leaf...

March 6, 2018

V.CLAS.H

RE:RE:RE:RE:RE:Former Kalytera CEO is M.D.Chairman at Salzman Group

No it is true, but would it not in fact prevent insider trading on account...

February 24, 2018

V.CLAS.H

RE:RE:Former Kalytera CEO is M.D.Chairman at Salzman Group

Monteviale, great way to summarize Salzman Group now owning over 2.3 MILLION...

February 23, 2018

V.CLAS.H

Former Kalytera CEO is M.D.Chairman at Salzman Group

Former Kalytera CEO Dr. Andrew L. Salzman is Chairman for Salzman Group. ...

February 23, 2018

V.CLAS.H

RE:Kalytera’s PreClinical Phases

(Link) KALYTERA.CO/PROGRAMS/ >>>>  Development Programs page...

February 13, 2018

T.FCU

RE:When RE coming?

Wouldn’t DML release their respective RE update first because they had the...

January 24, 2018

V.CLAS.H

RE:RE:Yup...got in at this floor

Kalytera Therapeutics, Inc. During the period, the Company sold its 6,172...

January 19, 2018

V.FDC

RE:Maurice Point Project

In the past they announced last week January after VRIC.  The mags and...

January 17, 2018

V.CLAS.H

Cannibis Killed Amelia Powers Brain Cancer

Watch strictly 3:35 thru 4:00 quote Amelia "God bless the God of...

January 16, 2018

V.CLAS.H

RE:Co-Chair of Kalytera's Scientific BOD Wall Street Journal

By  Amy Dockser Marcus April 11, 2016 11:26 a.m. ET 56...

January 16, 2018

V.CLAS.H

Former CEO Andrew Salzman is Chairman of Salzman Group

Former Kalytera CEO Dr. Andrew L. Salzman is Chairman or Salzman Group. ...

January 16, 2018